Amplicon-based NGS analysis allows targeting of previously identified variants, such as detecting mutations that cause resistance to anti-tumor treatments.

This approach requires a low DNA input (as little as 3 ng) and can be completed within a single day. However, amplicon-based NGS analysis provides information only on specific gene regions where primers are designed, not the entire gene. Additionally, the number of targets that can be analyzed in one reaction is limited.